Blog Archives

Why I'm Buying Tesla Stock - Why I Bought Over $20,000 in $TSLA Stock Today!

7/27/2020

Today I explain why I am buying Tesla Stock. I purchased over $20k in $TSLA today. Is Tesla stock too high? Am I crazy? Maybe. I provide Tesla stock analysis and why I'm buying TSLA stock.

From Seeking Alpha: "Summary: TSLA reported a GAAP profit in Q2, and are now eligible for S&P 500 inclusion. Inclusion in the index will lead to increased institutional buying, leading to lower cost of capital. Despite the inclusion of TSLA being seemingly inevitable, the stock is tapering off. This is likely due to the insane run-up in the stock heading into the report. Buy the dip. TSLA is becoming ever-so reminiscent of AMZN, a comparison I don't make lightly. The company's disruption of multiple industries and focus on reinvesting profits expose the similarities between the two companies. TSLA bears continue to grasp at straws and move goalposts, while the one of the most innovative companies in America eviscerates their short positions. The only legitimate barrier to entry with investing in TSLA is the valuation. Rating reiterated at BUY, PT remains $1,750. Tesla's Q2 Report: Sell The News With the hype surrounding Tesla's (NASDAQ:TSLA) second quarter earnings release, it seemed hard to see the stock racing any higher. Going into the report, retail, sell-side, and buy-side expectations seemed calibrated around a GAAP profit, and inclusion into the S&P 500. Anything other than this would have been disastrous for the stock. This was reflected in options pricing going into earnings. The implied move in the stock was among the highest of companies reporting earnings, standing at ~15% in either direction. If you think about it, with all the hype and increased expectations surrounding the report, a blowout of astronomical proportions would've been required to get that 15% move to the upside. Combined with the insane run-up and being technically overbought, a bit of a pullback was overdue. Why S&P 500 Inclusion Is Such A Huge Boost While S&P 500 index inclusion is not a direct fundamental catalyst right now, it could be a catalyst for the stock (in the short-term) and for the fundamentals of the business (in the long-term). What do I mean by this? Well, considering that Tesla reported a GAAP profit of $0.50/share in the Q2 report, the company has become eligible for S&P 500 index inclusion. This inclusion will increase institutional ownership of the stock. When the company is plugged into the S&P 500, index funds and mutual funds will be forced to enter a position in Tesla. A lot of these funds are buy-and-hold investors, not traders. Thus, a large portion of Tesla's float will be bought up by massive institutional holders. Because these managers hardly alter their positions, a large portion of the float will not be traded as frequently. This will likely lead to decreased volatility, which would lower Tesla's cost of capital. Though Tesla is firmly cash flow positive, and already has $8.6 billion in cash, one final massive capital raise could allow them too supercharge (no pun intended) their expansion plans. Think about it, Tesla is still set to expand Fremont factory, the Nevada Gigafactory, Gigafactory Shanghai, Gigafactory Texas, and Gigafactory Berlin. The last of those two factories will be the largest of Tesla's factories. The creation of these plants, and the ramp to full capacity production would be benefited immensely by a large capital raise. By being included into the S&P 500 index, not only will Tesla gain a prestige by being an S&P 500 component, certain investors will likely be forced to buy Tesla stock in order to get exposure to the S&P 500 index as a whole. Increased buying pressure from large institutional investors will likely lead to higher stock in the short-term, and a less volatile one in the long-term. Lower volatility leads to a lower cost of capital, making large scale equity-based (or convertible) capital raises easier to pull off." Tesla is already 2.47% of the Nasdaq 100 $QQQ.

Disclaimer: I have been investing in the stock market for over 20 years, but I am not a financial advisor or a legal professional, and I am not providing financial or legal advice. The information provided is for informational purposes only. It should not be considered legal or financial advice. You should consult with an attorney or other professional to determine what may be best for your individual needs. FIRED Up Wealth and Eric Cuka do not make any guarantee or other promise as to any results that may be obtained from using our content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is no guarantee of future results.

#stocks #Tesla #teslastock #highgrowth #evstocks

0 Comments

Renaissance IPO ETF Review - How to Buy Ant Financial IPO Stock? $IPO $IPOS

7/22/2020

0 Comments

Today I provide detailed stock analysis on Renaissance Capital ETF $IPO and $IPOS. $IPO could be an excellent way to play disruptive growth stock IPOs like Zoom, Crowdstrike, Moderna, Datadog, Uber, Pinduoduo, Slack, NIO, and many more! Could these ETFs also be the best way to play Ant Financial's upcoming IPO? Ant Group, an affiliate of Alibaba, announced plans for its long-awaited dual listing in Shanghai and Hong Kong on Monday. Ant Group runs Alipay, one of China’s most popular mobile payment apps, but has also been expanding into products such as wealth management and loans. Ant Group has not priced its shares yet, but one analyst said the company could be valued at over $200 billion. Ant will be the largest IPO of all time, but it will not be US listed. I will explain how to buy Ant Financial IPO stock / how to buy Ant Group stock if you do not have access to Shanghai or Hong Kong markets.

$IPO ETF holdings as of 7/21/20: 1 Zoom Video Communications ZM 10.13% 2 Uber Technologies UBER 8.62% 3 Pinduoduo PDD 7.51% 4 Moderna MRNA 7.15% 5 Datadog DDOG 4.55% 6 CrowdStrike Holdings CRWD 4.05% 7 Slack Technologies WORK 4.02% 8 NIO NIO 3.47% 9 Pinterest PINS 3.40% 10 Elanco Animal Health ELAN 3.12% 11 Avantor AVTR 2.53% 12 Tencent Music Entertainment Group TME 2.50% 13 Lyft LYFT 2.39% 14 Beyond Meat BYND 2.35% 15 Peloton Interactive PTON 2.19% 16 StoneCo STNE 2.16% 17 Dynatrace Holdings DT 2.15% 18 Livongo Health LVGO 2.01% 19 Guardant Health GH 1.99% 20 Anaplan PLAN 1.94% 21 BJ's Wholesale Club BJ 1.81% 22 10x Genomics TXG 1.71% 23 Farfetch FTCH 1.65% 24 Elastic ESTC 1.65% 25 Tradeweb Markets TW 1.53% 26 XP XP 1.44% 27 Cloudflare NET 1.37% 28 GSX Techedu GSX 1.25% 29 Royalty Pharma RPRX 1.08% 30 GFL Environmental GFL 0.98% 31 Adaptive Biotechnologies ADPT 0.91% 32 Chewy CHWY 0.86% 33 Vir Biotechnology VIR 0.79% 34 Warner Music Group WMG 0.72% 35 Allakos ALLK 0.66% 36 Allogene Therapeutics ALLO 0.66% 37 ZoomInfo Technologies ZI 0.64% 38 PPD PPD 0.63% 39 Reynolds Consumer Products REYN 0.54% 40 SolarWinds SWI 0.28% 41 OneConnect Financial Technology OCFT 0.26% 42 Levi Strauss & Co. LEVI 0.17% $IPOS ETF holdings as of 7/21/20: 1 Xiaomi 1810 Hong Kong 11.34% 2 Meituan-Dianping 3690 Hong Kong 10.82% 3 SoftBank Corp 9434 Japan 9.06% 4 China Tower Corp. 788 Hong Kong 5.79% 5 Innovent Biologics 1801 Hong Kong 5.33% 6 TeamViewer TMV Germany 4.43% 7 Nexi NEXI Italy 4.25% 8 Knorr-Bremse KBX Germany 3.87% 9 SIG Combibloc SIGN Switzerland 3.11% 10 Hansoh Pharmaceutical (Jiangsu) 3692 Hong Kong 3.06% 11 EQT Partners EQT Sweden 2.98% 12 Budweiser Brewing Company APAC 1876 Hong Kong 2.46% 13 Adevinta (Schibsted Classifieds fka MPI) ADE Norway 2.35% 14 Quilter (fka Old Mutual Wealth) QLT U.K. 2.30% 15 WuXi AppTec 2359 Hong Kong 2.01% 16 ESR Cayman 1821 Hong Kong 1.94% 17 Francaise des Jeux (FDJ) FDJ France 1.80% 18 Hapvida HAPV3 Brazil 1.75% 19 Network International NETW U.K. 1.75% 20 China Feihe 6186 Hong Kong 1.62% 21 CanSino Biologics 6185 Hong Kong 1.29% 22 Topsports International 6110 Hong Kong 1.11% 23 Haidilao International Holding 6862 Hong Kong 1.03% 24 Stadler Rail SRAIL Switzerland 1.02% 25 Tongcheng-eLong Holdings 780 Hong Kong 1.01% 26 Osotspa OSP Thailand 0.99% 27 Poly Property Development 6049 Hong Kong 0.99% 28 HDFC Asset Management (AMC) HDFCAMC India 0.93% 29 Shandong Gold Mining 1787 Hong Kong 0.86% 30 Traton (VW Heavy Truck (Volkswagen)) 8TRA Germany 0.73% 31 SBI Cards & Payment Services SBICARD India 0.68% 32 China East Education 667 Hong Kong 0.67% 33 Neoenergia NEOE3 Brazil 0.66% 34 Shanghai Junshi Biosciences 1877 Hong Kong 0.63% 35 Pharmaron Beijing 3759 Hong Kong 0.62% 36 Asset World Corp (AWC) AWC Thailand 0.61% 37 Ganfeng Lithium 1772 Hong Kong 0.55% 38 Embassy Office Parks REIT EMBASSY India 0.48% 39 Shenwan Hongyuan Group 6806 Hong Kong 0.37% 40 MallPlaza (Plaza S.A.) MALLPLAZA Chile 0.33%

Disclaimer: I have been investing in the stock market for over 20 years, but I am not a financial advisor or a legal professional, and I am not providing financial or legal advice. The information provided is for informational purposes only. It should not be considered legal or financial advice. You should consult with an attorney or other professional to determine what may be best for your individual needs. FIRED Up Wealth and Eric Cuka do not make any guarantee or other promise as to any results that may be obtained from using our content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is no guarantee of future results.

#ipo #stocks #antfinancial #highgrowth #ETF #alibaba

0 Comments

I'm Buying This Small Cap Growth Stock - Healthcare Cloud SaaS Multibagger Stock

7/17/2020

0 Comments

Today I discuss the small cap growth stock I'm buying now. This is a Cloud SaaS software stock in the healthcare industry. Their cloud-based software applications are designed to assist prescribers and pharmacists with patient engagement, identification of high risk patients, clinical decision support, documentation of clinical interactions, ordering medications and lab tests, and care management. Tabula Rasa Healthcare $TRHC is a leader in providing medication safety technology and services that enable prescribers and pharmacists to engage patients, optimize medication regimens, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. They deliver their solutions through technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and reminder packaging services for certain client populations with complex prescription needs. Many of their products and services are built around our novel and proprietary Medication Risk Mitigation Matrix, or MRM Matrix, which enables optimization of a patient's medication regimen, personalized medication selection, dosage levels, and time-of-day administration, and reduction of the total medication burden by eliminating unnecessary prescriptions. They believe they offer the first prospective clinical approach to medication risk management, which is designed to increase patient safety and promote adherence to a patient's personalized medication regimen.

Disclaimer: I have been investing in the stock market for over 20 years, but I am not a financial advisor or a legal professional, and I am not providing financial or legal advice. The information provided is for informational purposes only. It should not be considered legal or financial advice. You should consult with an attorney or other professional to determine what may be best for your individual needs. FIRED Up Wealth and Eric Cuka do not make any guarantee or other promise as to any results that may be obtained from using our content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is no guarantee of future results. #stocks #highgrowth #smallcapstocks #multibagger

0 Comments

Lemonade Insurance - New Disruptive Technology IPO Stock - Should You Buy $LMND?

7/1/2020

0 Comments

Today I cover Lemonade (LMND) stock, which has an IPO launch of July 2, 2020. Lemonade insurance uses Artificial Intelligence (AI) and chatbots (Maya) to replace salespeople. Lemonade offers renters and home insurance powered by tech and driven by social good. Should you buy this new disruptive-technology stock? Lemonade, the so-called insurtech backed by SoftBank Group, could raise as much as $308 million after increasing the price range for its much-anticipated initial public offering. Lemonade is expected to begin trading Thursday (July 2, 2020), Barron’s has learned. The New York–based start-up is selling 11 million shares at $26 to $28 each, according to a June 30 Securities and Exchange Commission filing. That’s up from the $23-$26 price range it had planned to offer. Lemonade is seen trading on the New York Stock Exchange under the ticker $LMND. "As the world is buffeted by digital and societal revolutions, Lemonade Inc. is hoping to leverage the uncertainty created by those upheavals to reshape an industry meant to provide peace of mind: insurance. Lemonade LMND, has filed for an initial public offering to be led by underwriters Goldman Sachs, Morgan Stanley, Allen & Co., Barclays, JMP Securities, Oppenheimer & Co., William Blair and LionTree. The New York-based company, founded in 2016, says in its filing with the Securities and Exchange Commission that it uses artificial intelligence and big-data algorithms to streamline the processes of buying insurance and filing claims, while minimizing volatility and “maximizing trust and social impact.” The company is attempting to approach the insurance industry the way companies like CrowdStrike Holdings Inc. CRWD, +2.65% and Salesforce.com Inc. CRM, +2.43% approached the software industry — by reimagining a legacy business for the world that exists now. Lemonade says it wants to be an insurance company “built from scratch on a digital substrate, a contemporary business model and no legacy.”

In 2018, Lemonade donated 2.7 percent of its leftover premiums to charity, totaling $162,000. In 2019, that increased to 3.5 percent when it donated $631,500. And given that the company has never not lost money, Lemonade’s investors seem the generous ones, standing by while their money is given out to charity. Meanwhile, Lemonade executive salaries totaled $1.5 million in 2019, and total executive compensation came to $6.3 million, a 10x amount compared to its charitable giving. What are the strengths for Lemonade stock? What are the risks of Lemonade stock? Should you buy LMND stock?

Disclaimer: I have been investing in the stock market for over 20 years, but I am not a financial advisor or a legal professional, and I am not providing financial or legal advice. The information provided is for informational purposes only. It should not be considered legal or financial advice. You should consult with an attorney or other professional to determine what may be best for your individual needs. FIRED Up Wealth and Eric Cuka do not make any guarantee or other promise as to any results that may be obtained from using our content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is no guarantee of future results. #stocks #IPO #Lemonade #highgrowth #LMND #aistocks

0 Comments

Eric Cuka’s Blog

Why I'm Buying Tesla Stock - Why I Bought Over $20,000 in $TSLA Stock Today!

Renaissance IPO ETF Review - How to Buy Ant Financial IPO Stock? $IPO $IPOS

I'm Buying This Small Cap Growth Stock - Healthcare Cloud SaaS Multibagger Stock

Lemonade Insurance - New Disruptive Technology IPO Stock - Should You Buy $LMND?

Archives

Categories